Latest News Subscribe

Market Review: June 30, 2025
US Indices 2025-12-28 09:26 source ↗

Market Review: June 30, 2025

Closing Recap

On June 30, 2025, U.S. stocks closed near their highs, marking the end of the month and the second quarter. The S&P 500 and Nasdaq Composite reached record closing levels, with the S&P 500 gaining 4.96% for the month and 10.57% for the quarter. The Nasdaq rose 6.57% in June and 17.75% in Q2, while the Dow increased by 4.31% and 4.98%, respectively. The strong performance was attributed to resumed trade talks with Canada and positive momentum in technology, financials, and industrials sectors.

Market Indices Performance

Index Change (Points) Change (%) Last Value
DJ Industrials 275.50 0.63% 44,094
S&P 500 31.88 0.52% 6,204
Nasdaq 96.28 0.48% 20,369
Russell 2000 2.51 0.12% 2,175

Economic Data

The Chicago PMI for June was reported at 40.4, below the consensus of 43.0, indicating continued contraction in economic activity. The index for prices paid rose, with 70% of respondents reporting higher prices, up from 57% in May.

Commodities and Currencies

Oil prices fell slightly, with WTI crude settling at $65.11 per barrel. The Euro reached a four-year high against the U.S. dollar, while the dollar itself hit lows not seen in four years. The 10-year Treasury yield decreased to 4.235% as discussions around lower interest rates continued.

Sector News Breakdown

Retail and Consumer Staples

Retail sales showed mixed results, with some companies like CELH and MNST performing well, while others like COCO saw a deceleration in growth. Big 5 Sporting Goods announced an acquisition deal valued at $112.7 million.

Energy

Solar and wind stocks experienced volatility due to proposed changes in tax incentives for renewable projects. Analysts had mixed views on the implications of the Senate's spending package on the energy sector.

Financials

Major banks reported strong performance following the Dodd-Frank Act Stress Test results, with all participant banks passing, indicating resilience against potential economic downturns.

Biotech and Pharma

AbbVie announced its acquisition of Capstan for $2.1 billion, while other companies reported mixed results in clinical trials and regulatory updates.

Conclusion

The market closed strong at the end of June, with positive momentum expected to carry into July, supported by favorable economic indicators and sector performances. Investors are looking ahead to upcoming job data and potential market movements.

Back to US Indices Email alerts subscription
Informational only. Not investment advice.